728 related articles for article (PubMed ID: 25479121)
1. High-resolution(18)F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for pituitary adenoma detection in Cushing disease.
Chittiboina P; Montgomery BK; Millo C; Herscovitch P; Lonser RR
J Neurosurg; 2015 Apr; 122(4):791-7. PubMed ID: 25479121
[TBL] [Abstract][Full Text] [Related]
2. CRH stimulation improves
Boyle J; Patronas NJ; Smirniotopoulos J; Herscovitch P; Dieckman W; Millo C; Maric D; Chatain GP; Hayes CP; Benzo S; Scott G; Edwards N; Ray Chaudhury A; Lodish MB; Sharma S; Nieman LK; Stratakis CA; Lonser RR; Chittiboina P
Endocrine; 2019 Jul; 65(1):155-165. PubMed ID: 31062234
[TBL] [Abstract][Full Text] [Related]
3. Comparison of MRI techniques for detecting microadenomas in Cushing's disease.
Grober Y; Grober H; Wintermark M; Jane JA; Oldfield EH
J Neurosurg; 2018 Apr; 128(4):1051-1057. PubMed ID: 28452619
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of composite methionine-positron emission tomography/3.0-tesla magnetic resonance imaging to detect the localization and extent of early-stage Cushing adenoma.
Ikeda H; Abe T; Watanabe K
J Neurosurg; 2010 Apr; 112(4):750-5. PubMed ID: 19698042
[TBL] [Abstract][Full Text] [Related]
5. Analysis of 18F-fluorodeoxyglucose positron emission tomography findings in patients with pituitary lesions.
Seok H; Lee EY; Choe EY; Yang WI; Kim JY; Shin DY; Cho HJ; Kim TS; Yun MJ; Lee JD; Lee EJ; Lim SK; Rhee Y
Korean J Intern Med; 2013 Jan; 28(1):81-8. PubMed ID: 23346000
[TBL] [Abstract][Full Text] [Related]
6. PET/MRI in the Diagnosis of Hormone-Producing Pituitary Microadenoma: A Prospective Pilot Study.
Wang H; Hou B; Lu L; Feng M; Zang J; Yao S; Feng F; Wang R; Li F; Zhu Z
J Nucl Med; 2018 Mar; 59(3):523-528. PubMed ID: 28775202
[TBL] [Abstract][Full Text] [Related]
7. Potential utility of FLAIR in MRI-negative Cushing's disease.
Chatain GP; Patronas N; Smirniotopoulos JG; Piazza M; Benzo S; Ray-Chaudhury A; Sharma S; Lodish M; Nieman L; Stratakis CA; Chittiboina P
J Neurosurg; 2018 Sep; 129(3):620-628. PubMed ID: 29027863
[TBL] [Abstract][Full Text] [Related]
8. Utility of
Wang Z; Mao Z; Zhang X; He D; Wang X; Du Q; Xiao Z; Zhu D; Zhu Y; Wang H
Acad Radiol; 2019 Sep; 26(9):1222-1228. PubMed ID: 30318288
[TBL] [Abstract][Full Text] [Related]
9. Detection of adrenocorticotropin-secreting pituitary adenomas by magnetic resonance imaging in children and adolescents with cushing disease.
Batista D; Courkoutsakis NA; Oldfield EH; Griffin KJ; Keil M; Patronas NJ; Stratakis CA
J Clin Endocrinol Metab; 2005 Sep; 90(9):5134-40. PubMed ID: 15941871
[TBL] [Abstract][Full Text] [Related]
10. Dexamethasone suppression for
Kim K; Kim DK; Moon JH; Kim EH; Kim SH; Ku CR; Lee EJ
Cancer Imaging; 2023 Sep; 23(1):85. PubMed ID: 37700359
[TBL] [Abstract][Full Text] [Related]
11. Utility of 11C-Methionine and 18F-FDG PET/CT in Patients With Functioning Pituitary Adenomas.
Feng Z; He D; Mao Z; Wang Z; Zhu Y; Zhang X; Wang H
Clin Nucl Med; 2016 Mar; 41(3):e130-4. PubMed ID: 26646998
[TBL] [Abstract][Full Text] [Related]
12. Preoperative Evaluation of Sellar and Parasellar Macrolesions by [
Tosaka M; Higuchi T; Horiguchi K; Osawa T; Arisaka Y; Fujita H; Tsushima Y; Yoshimoto Y
World Neurosurg; 2017 Jul; 103():591-599. PubMed ID: 28427982
[TBL] [Abstract][Full Text] [Related]
13. A role for 11C-methionine PET imaging in ACTH-dependent Cushing's syndrome.
Koulouri O; Steuwe A; Gillett D; Hoole AC; Powlson AS; Donnelly NA; Burnet NG; Antoun NM; Cheow H; Mannion RJ; Pickard JD; Gurnell M
Eur J Endocrinol; 2015 Oct; 173(4):M107-20. PubMed ID: 26245763
[TBL] [Abstract][Full Text] [Related]
14. Clinical application of combination [
Wang Z; Feng Z; Zhu D; Wang X; Chen J; Zhu Y; Wang H
BMC Endocr Disord; 2024 Feb; 24(1):19. PubMed ID: 38311763
[TBL] [Abstract][Full Text] [Related]
15. Prospective evaluation of the characteristics and incidence of adenoma-associated dural invasion in Cushing disease.
Lonser RR; Ksendzovsky A; Wind JJ; Vortmeyer AO; Oldfield EH
J Neurosurg; 2012 Feb; 116(2):272-9. PubMed ID: 21923247
[TBL] [Abstract][Full Text] [Related]
16. VENOUS SAMPLING FOR CUSHING DISEASE: COMPARISON OF INTERNAL JUGULAR VEIN AND INFERIOR PETROSAL SINUS SAMPLING.
Radvany MG; Quinones-Hinojosa A; Gallia GL; Wand GS; Salvatori R
Endocr Pract; 2016 Sep; 22(9):1057-61. PubMed ID: 27214296
[TBL] [Abstract][Full Text] [Related]
17. Incidental pituitary uptake on whole-body 18F-FDG PET/CT: a multicentre study.
Jeong SY; Lee SW; Lee HJ; Kang S; Seo JH; Chun KA; Cho IH; Won KS; Zeon SK; Ahn BC; Lee J
Eur J Nucl Med Mol Imaging; 2010 Dec; 37(12):2334-43. PubMed ID: 20661556
[TBL] [Abstract][Full Text] [Related]
18. The usefulness of combined biochemical tests in the diagnosis of Cushing's disease with negative pituitary magnetic resonance imaging.
Testa RM; Albiger N; Occhi G; Sanguin F; Scanarini M; Berlucchi S; Gardiman MP; Carollo C; Mantero F; Scaroni C
Eur J Endocrinol; 2007 Feb; 156(2):241-8. PubMed ID: 17287414
[TBL] [Abstract][Full Text] [Related]
19. Volume interpolated 3D-spoiled gradient echo sequence is better than dynamic contrast spin echo sequence for MRI detection of corticotropin secreting pituitary microadenomas.
Kasaliwal R; Sankhe SS; Lila AR; Budyal SR; Jagtap VS; Sarathi V; Kakade H; Bandgar T; Menon PS; Shah NS
Clin Endocrinol (Oxf); 2013 Jun; 78(6):825-30. PubMed ID: 23061773
[TBL] [Abstract][Full Text] [Related]
20. Ectopic Adrenocorticotropic Hormone-Secreting Pituitary Adenomas: An Underestimated Entity.
Knappe UJ; Jaspers C; Buschsieweke D; Reinbold WD; Alomari A; Saeger W; Ehlenz K; Mann WA; Kann PH; Feldkamp J
Neurosurgery; 2017 Apr; 80(4):525-533. PubMed ID: 27352274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]